A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants

NCT06103734 · clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Strategic decision to cancel the study based on adjusted clinical development plan.

Conditions

Interventions

Sponsor

Pfizer